...
首页> 外文期刊>Drug development and industrial pharmacy >The application of 'in-flight' laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
【24h】

The application of 'in-flight' laser diffraction to the particle size characterization of a model suspension metered dose inhaler.

机译:“飞行中”激光衍射在模型悬浮计量吸入器粒度表征中的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Laser diffraction (LD) has been used to measure the particle size of pharmaceutical aerosols. In this study, the application of LD for measuring the particle size of a model suspension metered dose inhaler (MDI) containing a hydrofluorocarbon propellant was investigated using a Sympatec LD apparatus with an automatic spray device. In order to obtain meaningful results, test parameters such as spray distance and temperature needed to be optimized for this model formulation and then well-controlled during testing. Using a suitable LD test methodology, it was found that particle size variations as a function of nonvolatile excipient levels as well as changes to the suspended drug substance could be observed and, in some cases, correlated to cascade impaction results. Based on these studies, it is believed that the methodology is a valuable rapid screening tool for investigating variations in or permutations to suspension MDI formulations. Nonetheless, the trends in the LD droplet size are complicated by the presence of drug-free droplets. Consequently, the results are not always consistent with other particle sizing techniques such as cascade impaction in which the droplets associated with drug are evaluated. Therefore, for suspension MDIs, the "in-flight" LD method would probably best be utilized as a complementary sizing technique during formulation development.
机译:激光衍射(LD)已用于测量药用气雾剂的粒径。在这项研究中,使用具有自动喷雾装置的Sympatec LD设备,研究了LD在测量含氢氟烃推进剂的模型悬浮计量吸入器(MDI)的粒径中的应用。为了获得有意义的结果,需要针对此模型公式优化测试参数(例如喷雾距离和温度),然后在测试过程中对其进行良好控制。使用合适的LD测试方法,发现可以观察到粒径随非挥发性赋形剂水平的变化以及悬浮药物的变化,并且在某些情况下与级联碰撞结果相关。基于这些研究,据信该方法是用于研究悬浮MDI制剂变化或排列变化的有价值的快速筛选工具。但是,LD液滴尺寸的趋势由于无药物液滴的存在而变得复杂。因此,结果并不总是与其他颗粒分级技术(例如级联碰撞)一致,在该技术中,与药物相关的液滴被评估。因此,对于悬浮MDI,在配方开发过程中,“飞行中” LD方法可能最好用作补充定径技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号